MD3940G2 - Metodă de tratament al paraliziei plexului brahial - Google Patents
Metodă de tratament al paraliziei plexului brahial Download PDFInfo
- Publication number
- MD3940G2 MD3940G2 MDA20080101A MD20080101A MD3940G2 MD 3940 G2 MD3940 G2 MD 3940G2 MD A20080101 A MDA20080101 A MD A20080101A MD 20080101 A MD20080101 A MD 20080101A MD 3940 G2 MD3940 G2 MD 3940G2
- Authority
- MD
- Moldova
- Prior art keywords
- days
- day
- homaccord
- biologically active
- compositum
- Prior art date
Links
- 206010033799 Paralysis Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000007924 injection Substances 0.000 abstract 2
- 238000002347 injection Methods 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 239000009993 Lymphomyosot Substances 0.000 abstract 1
- 239000008955 Traumeel S Substances 0.000 abstract 1
- 210000004720 cerebrum Anatomy 0.000 abstract 1
- 239000005515 coenzyme Substances 0.000 abstract 1
- 230000002354 daily effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000003203 everyday effect Effects 0.000 abstract 1
- SOECUQMRSRVZQQ-UHFFFAOYSA-N ubiquinone-1 Chemical compound COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O SOECUQMRSRVZQQ-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Invenţia se referă la medicină, neurologie, pediatrie şi este destinată tratamentului paraliziilor plexului brahial la nou-născuţi şi sugari.Metoda, conform invenţiei, constă în aceea că se administrează per os Bryaconeel şi Nervoheel câte ¼… 1/2 pastilă de 3 ori pe zi timp de 1 lună; Cinnamomum-Homaccord N, Lymphomyosot şi Galium-Heel N de 3 ori pe zi câte 3…5 picături timp de 1 lună; subcutanat Traumeel S câte 0,4…0,8 ml zilnic în primele 3 zile, apoi peste 1 zi, Cerebrum Compositum N câte 0,4…0,8 ml peste 3 zile, Gelsemium-Homaccord câte 0,3…0,5 ml peste 2 zile, Ferrum-Homaccord câte 0,3…0,5 ml peste 3 zile, Circulo-Injeel câte 0,3…0,6 ml de 2 ori pe săptămână, la o serie de tratament de 7…10 injecţii, de asemenea Coenzyme compositum şi Ubichinon Compositum câte 0,3…0,5 ml o dată pe săptămână, la o serie de tratament de 2…4 injecţii. Totodată, preparatele menţionate se administrează în următoarele puncte biologic active: T14; V11; IG 2-8, 12,15; VB21; G 5-12, 14-15; P5,9; C3-8; MC3-9; TR3-10; AP37,41,55,63,64,65,66. În fiecare punct biologic activ se introduce un singur preparat medicamentos menţionat câte 0,1…0,3 ml, care se administrează în 3…5 puncte, totodată în fiecare zi se selectează diferite puncte biologic active.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20080101A MD3940G2 (ro) | 2008-04-07 | 2008-04-07 | Metodă de tratament al paraliziei plexului brahial |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20080101A MD3940G2 (ro) | 2008-04-07 | 2008-04-07 | Metodă de tratament al paraliziei plexului brahial |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD3940F1 MD3940F1 (ro) | 2009-07-31 |
| MD3940G2 true MD3940G2 (ro) | 2010-02-28 |
Family
ID=40941130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20080101A MD3940G2 (ro) | 2008-04-07 | 2008-04-07 | Metodă de tratament al paraliziei plexului brahial |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD3940G2 (ro) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA59569A (uk) * | 2002-08-08 | 2003-09-15 | В'ячеслав Євгенович Сотниченко | Спосіб лікування хворих з паралічем плечового сплетіння та пристрій для його здійснення |
-
2008
- 2008-04-07 MD MDA20080101A patent/MD3940G2/ro not_active IP Right Cessation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA59569A (uk) * | 2002-08-08 | 2003-09-15 | В'ячеслав Євгенович Сотниченко | Спосіб лікування хворих з паралічем плечового сплетіння та пристрій для його здійснення |
Also Published As
| Publication number | Publication date |
|---|---|
| MD3940F1 (ro) | 2009-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ630790A (en) | Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes | |
| JP2016514132A5 (ro) | ||
| PH12021551747A1 (en) | Composition for treating diabetes, containing long-acting insulin analog conjugate and long-acting insulin secretion peptide conjugate | |
| MX2011007854A (es) | Metodos para tratar infartos agudos al miocardio y trastornos relacionados. | |
| WO2016109823A8 (en) | Treatment of pediatric growth hormone deficiency with human growth hormone analogues | |
| HU3526U (en) | Blister card | |
| MD3940G2 (ro) | Metodă de tratament al paraliziei plexului brahial | |
| MD3803G2 (ro) | Metodă de tratament al hiperchineziilor la copii | |
| Berenson et al. | Pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed/refractory multiple myeloma: results from a phase 1/2 trial | |
| MX2012005497A (es) | Tivozanib y temsirolimus en combinacion. | |
| CN105232577A (zh) | 一种脂肪来源干细胞因子的生发技术 | |
| PH12014502494A1 (en) | Parenteral esmolol formulation | |
| MD3927G2 (ro) | Metodă de tratament al paraliziei faciale | |
| Lozano-Blasco | Immune globulin | |
| Time | Clinical Trials of Interferon Alfa in Locally Advanced or Metastatic Renal Cell Carcinoma | |
| Schaub et al. | Pharmacokinetics and Pharmacodynamics after Subcutaneous Dosing of the iNKT Cell Depleting Antibody NKTT120 | |
| UA47304U (ru) | Способ лечения хронических рецидивирующих пиодермий | |
| UA64881U (ru) | Способ лечения печеночной недостаточности пострадавших с травмой печени | |
| Song | Arsenic trioxide | |
| Koch | Hyperthyroidism and radioiodine | |
| UA37228U (ru) | Способ лечения фетоплацентарной недостаточности у беременных с гипертензивными расстройствами | |
| Carlson | Metastatic Colorectal Cancer: TAS-102, Regorafenib Trials ‘Unequivocally Positive’ | |
| MX2019009733A (es) | 3'-deamino-3'-(2''-pirrolin-1''-il)-5-imino-13-desoxiantraciclina s y metodos de preparacion. | |
| Park | Delayed hypersensitivity: case report | |
| Miyoshi | Autologous formalin fixed tumour cell vaccine/pembrolizumab |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |